Archived on: July 1, 2009. This document may contain dated information. It remains available to provide access to historical materials.
This assessment is an outgrowth of a partnership between the NDIC and HIDTA Program for preparation of annual assessments depicting drug trafficking trends and developments in HIDTA Program areas. The report has been vetted with the HIDTA, is limited in scope to HIDTA jurisdictional boundaries, and draws upon a wide variety of sources within those boundaries.
Your questions, comments, and suggestions for future subjects are welcome at
any time. Addresses are provided at the end of the page.
Strategic Drug Threat Developments
Drug Trafficking Organizations
Figure 1. Washington/Baltimore High Intensity Drug Trafficking
Area.
Figure 2. Washington/Baltimore HIDTA
transportation infrastructure.
Figure 1. Washington/Baltimore High Intensity Drug Trafficking Area
Map showing the Washington/Baltimore High Intensity Drug Trafficking Area.
The W/B HIDTA region encompasses four distinct population centers--the Baltimore Metropolitan Area, the District of Columbia, Northern Virginia, and the Richmond metropolitan area. The region includes the following county and city jurisdictions: Maryland (Anne Arundel, Baltimore, Charles, Howard, Montgomery, and Prince George's Counties and the city of Baltimore); Northern Virginia (Arlington, Fairfax, Loudoun, and Prince William Counties and the cities of Alexandria, Fairfax, and Manassas); the Richmond metropolitan area (Chesterfield, Hanover, Henrico, and Prince George Counties and the cities of Colonial Heights, Hopewell, Petersburg, and Richmond); and Washington, D.C.
This assessment provides a strategic overview of the illicit drug situation in the Washington/Baltimore (W/B) High Intensity Drug Trafficking Area (HIDTA), highlighting significant trends and law enforcement concerns relating to the trafficking and abuse of illicit drugs. The report was prepared through detailed analysis of recent law enforcement reporting, information obtained through interviews with law enforcement and public health officials, and available statistical data. The report is designed to provide policymakers, resource planners, and law enforcement officials with a focused discussion of key drug issues and developments facing the W/B HIDTA.
National Drug Intelligence Center
319 Washington Street, 5th Floor
Johnstown, PA 15901-1622
Tel. (814) 532-4601
FAX (814) 532-4690
Email NDIC.Contacts@usdoj.gov
National Drug Intelligence Center
United States Department of Justice
Robert F. Kennedy Building (Room 1335)
950 Pennsylvania Avenue NW
Washington, DC 20530
Tel. (202) 432-4040
FAX (202) 514-4252
ADNET: http://ndicosa
DOJ: http://www.usdoj.gov/archive/ndic/
LEO: https://cgate.leo.gov/http/leowcs.leopriv.gov/lesig/archive/ndic/index.htm
RISS: ndic.riss.net
To Top To Contents To Next Page
To Publications Page To Home Page
End of page.